Public-registry site landscape for NCT07680790, a Non-Small Cell Lung Cancer study sponsored by Bristol-Myers Squibb. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07680790 (registry record) |
| Sponsor | Bristol-Myers Squibb |
| Condition(s) | Non-Small Cell Lung Cancer |
| Phase | PHASE3 |
| Listed sites | 180 |
| Site countries | United States, Australia, Canada, China, France, Germany, India, Italy, Japan, South Korea, Spain, Taiwan |
At Local Institution - 0212 — one of the facilities listed on this trial — 1 other study is actively recruiting Non-Small Cell Lung Cancer patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07680790 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →